QuidelOrtho Corporation Registered Shs News

QuidelOrtho Corporation Registered Shs Aktie VALOR 119356965 / ISIN US2197981051

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Trading-Depot

Aktion

Portfolio

Watchlist

13.01.25	QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024 (Businesswire)
31.12.24	QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Businesswire)
10.12.24	QuidelOrtho Announces Appointment of Two Independent Directors to its Board (Businesswire)
20.11.24	QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group (Businesswire)
19.11.24	QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group (Businesswire)
28.10.24	QuidelOrtho to Participate in Three Upcoming Investor Conferences (Businesswire)
17.10.24	QuidelOrtho to Report Third Quarter 2024 Financial Results (Businesswire)
09.10.24	QuidelOrtho Announces New R&D Executive Leader (Businesswire)
10.09.24	QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer (Businesswire)
29.08.24	VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S. (Businesswire)
19.08.24	QuidelOrtho to Participate in Upcoming Investor Conferences (Businesswire)
17.07.24	QuidelOrtho to Report Second Quarter 2024 Financial Results (Businesswire)
23.05.24	QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference (Businesswire)
15.05.24	QuidelOrtho Opens New Distribution Center in Pedricktown, NJ (Businesswire)
08.05.24	QuidelOrtho Reports First Quarter 2024 Financial Results (Businesswire)
02.05.24	QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer (Businesswire)
17.04.24	QuidelOrtho To Report First Quarter 2024 Financial Results (Businesswire)
10.04.24	QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay (Businesswire)

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Kuehne+Nagel Int	187.25	1.57 %	K V
Swisscom	671.50	0.75 %	K V
Zurich Insur Gr	570.80	0.53 %	K V
Alcon	60.32	0.40 %	K V
Swiss Re	132.30	0.38 %	K V
Sika	131.40	-0.61 %	K V
ABB	65.84	-0.66 %	K V
Holcim	67.20	-0.88 %	K V
Geberit	530.20	-1.30 %	K V
Amrize	43.64	-1.76 %	K V